(RTTNews) - Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biotechnology company, Monaday unveiled new preclinical and clinical data on icovamenib at the Advanced Technologies & Treatments for ...
(RTTNews) - Glucotrack, Inc. (GCTK), Wednesday, announced the results from its first-in-human trial of its continuous blood glucose monitoring or CBGM system, which will be presented at the 2025 ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. While we don't expect tonight's Monday Night Football matchup to turn into a track meet, there are a number of intriguing ...
Presentations highlight real‑world dosing and titration patterns in youth, and post‑prandial glucose management strategies using inhaled insulin in both adults and youth with T1D Data to be featured ...
Poster highlights how healthcare expertise and lived screening experience together can help individuals move from awareness to action. RALEIGH, AL, UNITED STATES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results